Sodium Hydroxide → 5-(4-Methyl-1-piperazinyl)-11H-imidazo(1,2-C)(1,3)benzodiazepine
Reaction equation
[C:1]([N:6]1[CH2:11][CH2:10][N:9]([C:12]2[N:18]3[CH:19]=[CH:20][N:21]=[C:17]3[CH2:16][C:15]3[CH:22]=[CH:23][CH:24]=[CH:25][C:14]=3[N:13]=2)[CH2:8][CH2:7]1)(OCC)=O.[H-].[Al+3].[Li+].[H-].[H-].[H-].[OH-].[Na+]>O1CCCC1>[CH3:1][N:6]1[CH2:7][CH2:8][N:9]([C:12]2[N:18]3[CH:19]=[CH:20][N:21]=[C:17]3[CH2:16][C:15]3[CH:22]=[CH:23][CH:24]=[CH:25][C:14]=3[N:13]=2)[CH2:10][CH2:11]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 0.2 g of 5-(4-carboethoxy-1-piperazinyl)-11H-imidazo[1,2-c][1,3]benzodiazepine in 2 ml of dry tetrahydrofuran, 100 mg of lithium aluminum hydride are added at once and the mixture is refluxed under nitrogen for 48 hours. The mixture is cooled to room temperature, stirred with 0.2 ml of 30% sodium hydroxide, and filtered. the filtrates are evaporated to dryness and the product is purified to give 5-(4-methyl-1-piperazinyl)-11H-imidazo[1,2-c][1,3]benzodiazepine.
Workup
- temperatureis refluxed under nitrogen for 48 hours
- filtrationfiltered
- customthe filtrates are evaporated to dryness
- customthe product is purified
Sources & evidence
- ORD record
- ord-e2ffaaa69ee24812b816c7b5d4c58a09
- Source dataset
- uspto-grants-1985_03
- Patent number
- US04507311
Reaction notes
Loading…